2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Cancer genetics<br />
<strong>of</strong> UVs newly found in patients .<br />
We used different publicly available programs and web-based tools to<br />
identify UVs that may have deleterious effects with respect to different<br />
biomolecular functional categories (splicing regulation, transcriptional<br />
regulation, nonsynonymous amino acid SNP effect . . .) so their clinical<br />
significance in cancer etiology could be assumed.<br />
Using straightforward physical and comparative considerations, we<br />
have found that several sequence variants with nonsynonymous amino<br />
acid change could have possible impact on the structure and function<br />
<strong>of</strong> a BRCA1 and BRCA2 proteins . Synonymous amino acid changes<br />
(silent mutations) could have impact on splicing regulation by disrupting<br />
exonic splice enhancers . Intronic sequence variants showed no<br />
potential impact on splicing because nucleotide changes at that positions<br />
likely make no changes in consensus splice sites .<br />
In Silico analysis <strong>of</strong> BRCA1 and BRCA2 presents fast, easy and cheap<br />
method for assessing preliminary clinical significance for UVs, especially<br />
in cases with low frequency and ethnic specific alleles, when<br />
it is difficult to make population based studies and when expensive<br />
experimental functional assays must be performed .<br />
P04.069<br />
three years <strong>of</strong> real-time PcR-based gene dosage for<br />
BRCA large rearrangements in France : new perspective in<br />
combination with HRm curve analysis<br />
C. Lefol, E. Rouleau, G. Christophe, F. Copigny, C. Andrieu, I. Bieche, R. Lidereau;<br />
Centre Rene Huguenin, St Cloud, France.<br />
BRCA1 germline mutations are responsible for susceptibility in breastovarian<br />
cancers . Some alterations are large rearrangements (15%) .<br />
To detect them, our laboratory has proposed a real-time PCR-based<br />
gene dosage . Since 2004, samples from all <strong>of</strong> over France have been<br />
analyzed with this method to confirm large rearrangements detected<br />
with semi-quantitative multiplex PCR (MLPA or QMPSF) . Recently, our<br />
qPCR experience have been transfer to LightCycler 480 combining<br />
High-Resolution Melting curve analysis .<br />
For each genomic DNAs sent, suspected exons were scanned with<br />
a few others . Copy numbers <strong>of</strong> each exon were calculated with an<br />
algorithm based on delta Ct method . As reference <strong>of</strong> the diploidy, three<br />
genes (4q, 8q, 17q) were quantified.<br />
148 samples have been analysed with ABI Prism 7900 and PowerSybr<br />
Mix. 49 rearrangements were confirmed (table). 99 samples have no<br />
rearrangement . Most <strong>of</strong> those BRCA1 large rearrangements were analysed<br />
and validated with LightCycler 480 and HRM Master Mix using<br />
the same qPCR primers . Furthermore, by applying the same algorithm<br />
and PCR conditions, selected HRM primers were also able to detect<br />
those rearrangements .<br />
This large series confirms the abilities <strong>of</strong> qPCR to detect large rearrangements<br />
in a routine screening . HRM curve analysis combined with<br />
quantitative PCR can give in unique assay information for point mutations<br />
and large rearrangements . Therefore, this technique should be<br />
reconsidered as a first-line tool for BRCA1 screening .<br />
Result <strong>of</strong> 148 suspected BRCA1 large rearrangements by real-time<br />
PCR-based gene dosage<br />
Number <strong>of</strong> Number <strong>of</strong> con-<br />
%<br />
samples firmation<br />
Deletion suspected 101 35 35%<br />
Duplication suspected<br />
16 4 25%<br />
(5’region to exon 1-2)<br />
Duplication suspected<br />
31 10 30%<br />
(others exons)<br />
P04.070<br />
characterization <strong>of</strong> some acute lymphoblastic leukemia cases<br />
by cytogenetic technique<br />
D. Usurelu1 , L. Gavrila1 , D. Cimponeriu1 , P. Apostol1 , L. Dan1 , I. Radu1 , V. Teleanu2<br />
, A. Moicean2 , A. Dumitrescu2 ;<br />
1 2 Institute <strong>of</strong> <strong>Genetics</strong>, Bucharest, Romania, Fundeni Hospital, Bucharest, Romania.<br />
Cytogenetical analyses are important for diagnostics, prognostic and<br />
monitoring <strong>of</strong> the treatment efficiency in leukemia.<br />
Objective:<br />
Cytogenetical characterization <strong>of</strong> some Romanian patients with acute<br />
lymphoblastic leukemia (ALL) .<br />
material and methods:<br />
Five patients with ALL from Fundeni hospital, Bucharest were analyzed<br />
.<br />
Bone marrow cells were cultivated in specific medium for 96 hours. The<br />
slides were prepared according to the classical procedure and stained<br />
with Giemsa solution . 100 metaphases/patient were analyzed .<br />
The cytogenetic analyses follow two directions:<br />
- detection <strong>of</strong> chromosomal aberrations and identification <strong>of</strong> t(9;22)<br />
- evaluation <strong>of</strong> a potential link between leukemic phenotype and the<br />
telomeres structure .<br />
Results and conclusion:<br />
An obvious genomic instability <strong>of</strong> the leukemic cells was noticed, expressed<br />
by different chromosomal rearrangements, as well as by genomic<br />
mutation i .e . aneuploidy (table) .<br />
Chromosomal rearrangements<br />
Normal<br />
Telomere-to-telomere<br />
Patients<br />
Aneuploidy<br />
ring chromo-<br />
metaphases PCD<br />
and telomere-to- centro- Fusions<br />
(>50chromosomes)<br />
somesmere<br />
attractions<br />
1 43 10 1 8 12 0<br />
2 55 15 3 2 7 1<br />
3 29 11 0 1 5 0<br />
4 48 13 8 3 3 2<br />
5 35 20 5 7 7 0<br />
The FISH analyses showed the t(9;22) was present in two patients. This translocation<br />
was present in 57% <strong>of</strong> the metaphases <strong>of</strong> the first patient and in 71% <strong>of</strong> the metaphases<br />
<strong>of</strong> the third one.<br />
No correlation between the telomere length and the leukemic phenotype could be<br />
detected. The fluorescence signal was encountered in more than 97% <strong>of</strong> the chromosomes,<br />
that indicates almost intact telomeric repetition, without large terminal deletions.<br />
The incidence <strong>of</strong> t(9;22) found in two out <strong>of</strong> five patients is comparable to other studies<br />
taking in acount also that they didn’t receive any treatment, being at the diagnostic<br />
stage.<br />
P04.071<br />
chromosomes 3 and 7 rearrangements in complex<br />
chromosomal aberrations in patients with myelodysplastic<br />
syndromes and acute myeloid leukemia<br />
J. Brezinova 1 , Z. Zemanova 2 , L. Babicka 2 , S. Izakova 1 , J. Cermak 1 , M. Siskova<br />
3 , K. Michalova 1,2 ;<br />
1 Institute <strong>of</strong> Hematology and Blood Transfusion, Prague, Czech Republic,<br />
2 Center <strong>of</strong> Oncocytogenetics Institute <strong>of</strong> Clinical Biochemistry and Laboratory<br />
Diagnostics General Faculty Hospital and 1st Faculty <strong>of</strong> Medicine <strong>of</strong> Charles<br />
University, Prague, Czech Republic, 3 1st Medical Department General Faculty<br />
Hospital and 1st Faculty <strong>of</strong> Medicine <strong>of</strong> Charles University, Prague, Czech<br />
Republic.<br />
Rearrangements <strong>of</strong> chromosomes 3 and 7 are frequent in myelodysplastic<br />
syndromes (MDS) and acute myeloid leukemia (AML) and are<br />
associated with poor outcome and resistance to treatment . Combinations<br />
<strong>of</strong> molecular cytogenetic techniques were used for identification<br />
<strong>of</strong> these rearrangements in bone marrow cells <strong>of</strong> patients with complex<br />
chromosomal aberrations (CCA) . In cohort <strong>of</strong> 392 patients with AML<br />
and RAEBt (refractory anemia with excess blast in transformation) we<br />
proved CCA in 58 <strong>of</strong> them . Chromosome 3 was involved in complex<br />
aberrations in 26 patients, chromosome 7 in 23 patients, both chromosomes<br />
3 and 7 in nine patients . The most frequent aberrations <strong>of</strong><br />
chromosome 3 were non-reciprocal translocation combined with deletion<br />
<strong>of</strong> chromosome 3 (14 patients) . Other abnormalities proved by<br />
FISH: non-reciprocal translocations without deletion (8 patients), reciprocal<br />
translocation (5 patients), partial trisomy (4 patients), inversion<br />
(1 patient) and insertion <strong>of</strong> a part <strong>of</strong> chromosome 3 into chromosome<br />
2 (1 patient) . Breakpoints 3p24 .2 and 3q26 were the most frequent .<br />
Minimal deleted segment 3p25-3pter was ascertained in 12 patients .<br />
Similarly, large heterogeneity <strong>of</strong> the breakpoints and various extent <strong>of</strong><br />
deletion were proved on chromosome 7 with the most frequent breakpoints<br />
7q31 and 7p12 . Partners in translocations were chromosomes<br />
5, 3 and 12 . Using combination <strong>of</strong> molecular cytogenetic techniques<br />
we found a wide variety <strong>of</strong> aberrations not detectable by conventional<br />
cytogenetic analysis . We presume contribution <strong>of</strong> more genes and participation<br />
<strong>of</strong> epigenetic factors in the origin and during the course <strong>of</strong><br />
the disease .<br />
Supported by grants IGA NR 9227-3, MZO 00023736, MSMT LC535 .<br />
0